PURPOSE: We describe infrared regional pupillometry as an objective comparative assessment of midperipheral to central retinal sensitivity and to correlate with midperipheral retinal ischemia in diabetic subjects. METHODS: We tested 12 normal and 17 diabetic subjects using bilateral infrared pupillometry. The diabetic cohort included seven subjects without, five with mild, three with moderate, and two with severe non-proliferative diabetic retinopathy (NPDR). Central and annular stimuli of varying intensity were presented to one eye, and pupillary amplitude and constriction velocity were measured from both eyes. Light stimulus of increasing intensity was presented as 20 consecutive trials (stimulus duration of 300 ms with 3000 ms intervals). The ratio of central to peripheral responses (Q values) was calculated for each stimulus configuration. Average responses with respect to the stimulus strength were regressed with Gompertz sigmoid function. RESULTS: Control and moderate/severe NPDR cases comparison showed statistically significant differences in amplitude (Q(A)) and constriction velocity (Q(CV)) (Wilcoxon rank sum test P = 0.002, respectively). Age difference for these groups was not statistically significant (Wilcoxon rank sum test P = 0.15). The comparison of control and diabetic subjects without NPDR/mild NPDR was statistically significant for Q(A) and Q(CV) (Wilcoxon rank sum test P = 0.0002 and P = 0.001, respectively). Q(A) and Q(CV) differences were statistically significant between moderate/severe NPDR cases and subjects without or mild NPDR cases (Wilcoxon rank sum test P = 0.013). CONCLUSIONS: Q(A) and Q(CV) values correlated highly with the severity of diabetic retinopathy, but not with the duration of diabetes.
PURPOSE: We describe infrared regional pupillometry as an objective comparative assessment of midperipheral to central retinal sensitivity and to correlate with midperipheral retinal ischemia in diabetic subjects. METHODS: We tested 12 normal and 17 diabetic subjects using bilateral infrared pupillometry. The diabetic cohort included seven subjects without, five with mild, three with moderate, and two with severe non-proliferative diabetic retinopathy (NPDR). Central and annular stimuli of varying intensity were presented to one eye, and pupillary amplitude and constriction velocity were measured from both eyes. Light stimulus of increasing intensity was presented as 20 consecutive trials (stimulus duration of 300 ms with 3000 ms intervals). The ratio of central to peripheral responses (Q values) was calculated for each stimulus configuration. Average responses with respect to the stimulus strength were regressed with Gompertz sigmoid function. RESULTS: Control and moderate/severe NPDR cases comparison showed statistically significant differences in amplitude (Q(A)) and constriction velocity (Q(CV)) (Wilcoxon rank sum test P = 0.002, respectively). Age difference for these groups was not statistically significant (Wilcoxon rank sum test P = 0.15). The comparison of control and diabetic subjects without NPDR/mild NPDR was statistically significant for Q(A) and Q(CV) (Wilcoxon rank sum test P = 0.0002 and P = 0.001, respectively). Q(A) and Q(CV) differences were statistically significant between moderate/severe NPDR cases and subjects without or mild NPDR cases (Wilcoxon rank sum test P = 0.013). CONCLUSIONS: Q(A) and Q(CV) values correlated highly with the severity of diabetic retinopathy, but not with the duration of diabetes.
Authors: Xinzhi Zhang; Jinan B Saaddine; Chiu-Fang Chou; Mary Frances Cotch; Yiling J Cheng; Linda S Geiss; Edward W Gregg; Ann L Albright; Barbara E K Klein; Ronald Klein Journal: JAMA Date: 2010-08-11 Impact factor: 56.272
Authors: G P Sampson; A M Shahidi; D Vagenas; N Pritchard; K Edwards; A W Russell; R A Malik; N Efron Journal: Diabetologia Date: 2012-01-19 Impact factor: 10.122
Authors: April Y Maa; William J Feuer; C Quentin Davis; Ensa K Pillow; Tara D Brown; Rachel M Caywood; Joel E Chasan; Stephen R Fransen Journal: J Diabetes Complications Date: 2015-12-09 Impact factor: 2.852
Authors: Hasan Kızıltoprak; Kemal Tekin; Mehmet Ali Sekeroglu; Esat Yetkin; Sibel Doguizi; Pelin Yilmazbas Journal: Neuroophthalmology Date: 2019-11-25
Authors: A V Rukmini; Milton C Chew; Maxwell T Finkelstein; Eray Atalay; Mani Baskaran; Monisha E Nongpiur; Joshua J Gooley; Tin Aung; Dan Milea; Raymond P Najjar Journal: Sci Rep Date: 2019-03-20 Impact factor: 4.379
Authors: Michael D Abramoff; Patrice E Fort; Ian C Han; K Thiran Jayasundera; Elliott H Sohn; Thomas W Gardner Journal: Invest Ophthalmol Vis Sci Date: 2018-01-01 Impact factor: 4.799